Physiological growth factor receptors and extracellular matrix components

Physiological growth factor receptors and extracellular matrix (ECM) components represent a broad functional category of biological molecules rather than a single therapeutic target. Growth factor receptors, such as the Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR) families, are critical transmembrane proteins that translate extracellular signals into cellular responses like growth and survival (Source: NIH/NCBI). The extracellular matrix is a complex network of proteins, including collagen, laminin, and fibronectin, that provides structural support and biochemical cues to surrounding cells (Source: UniProt). In many diseases, particularly cancer and fibrosis, these components are dysregulated; for instance, overactive growth factor signaling can drive tumor progression, while excessive ECM deposition leads to organ scarring (Source: PubMed). Because this term encompasses hundreds of distinct proteins across multiple families, it is classified as a category of targets rather than a specific molecular entity. Therapeutic strategies targeting this group include monoclonal antibodies that block ligand binding and small molecules that inhibit intracellular kinase activity.

Other names

Growth factor receptorsExtracellular matrix proteinsECM componentsCell surface receptors and matrix proteins

Inhibition of ligand-receptor binding, blockade of receptor tyrosine kinase phosphorylation, or modulation of cell-matrix adhesion and ECM degradation.